Amondys 45™ (casimersen)
Full Name | Amondys 45™ (casimersen) |
Drug | Amondys 45 |
Manufacturer | Sarepta Therapeutics, Inc. |
Route of Administration | Intravenous |
Site of Care | Home or Healthcare Facility |
Approved Indication | Treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping |
Disease | Duchenne Muscular Dystrophy (DMD) |
Therapeutic Area | Neurology |
Enrollment Form Link | Enrollment Form |
Phone Number | 800-356-5034 |
Fax Number | 877-339-4602 |
Product Website | amondys45.com |